In addition, a significantly higher proportion of NKT-like (CD56+CD3+) cells from current smokers with COPD (87.5%, 80.0–93.3; p<0.005,) were activated compared to healthy smokers (34.8%, 19.4–47.7) (Figure 5B). This evidence concerns the gene NCAM1 and chronic obstructive pulmonary disease.